MUMBAI, India, Oct. 26 -- Intellectual Property India has published a patent application (202617090138 A) filed by Obsidian Therapeutics, Inc. on July 24, 2026, for Compositions And Methods For Tunable Regulation Of Il15 And Light.
Inventors include Passaro, Carmela; Sethi, Dhruv; Ter Meulen, Jan; and Ols, Michelle.
The application for the patent was published on October 23, 2026, under issue no. 43/2026.
Abstract: Provided herein are nucleic acid molecules comprising a first nucleic acid encoding a polypeptide payload operably linked to a first drug responsive domain (DRD) and a second nucleic acid encoding a LIGHT polypeptide operably linked to a second DRD. The abundance, availability, and/or biological activity of the polypeptide pay...